Technical Analysis for INSY - Insys Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 7.88 1.16% 0.09
INSY closed up 1.16 percent on Friday, February 23, 2018, on 14 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
9 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical INSY trend table...

Date Alert Name Type % Chg
Feb 23 NR7 Range Contraction 0.00%
Feb 23 Wide Bands Range Expansion 0.00%
Feb 22 Wide Bands Range Expansion 1.16%
Feb 21 Wide Bands Range Expansion -0.63%
Feb 20 Wide Bands Range Expansion 3.82%
Feb 20 Down 3 Days in a Row Weakness 3.82%
Feb 20 Oversold Stochastic Weakness 3.82%
Feb 16 Wide Bands Range Expansion 1.16%
Feb 15 50 DMA Resistance Bearish -2.72%
Feb 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.72%

Older signals for INSY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
INSYS Therapeutics, Inc., a development stage company, develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray, a single-use product for the treatment of breakthrough cancer pain; and Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution, which completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting, and appetite stimulation in AIDS patients. It also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid liposomal, which is in Phase II clinical development stage to enhance efficacy and reduce paclitaxel-related side effects. The company was founded in 2002 and is based in Phoenix, Arizona.
Is INSY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.02
52 Week Low 4.1
Average Volume 1,856,630
200-Day Moving Average 9.3175
50-Day Moving Average 8.6058
20-Day Moving Average 8.424
10-Day Moving Average 7.896
Average True Range 0.5946
ADX 18.9
+DI 18.97
-DI 24.73
Chandelier Exit (Long, 3 ATRs ) 8.9862
Chandelier Exit (Short, 3 ATRs ) 8.9638
Upper Bollinger Band 9.9484
Lower Bollinger Band 6.8996
Percent B (%b) 0.32
BandWidth 36.191833
MACD Line -0.2911
MACD Signal Line -0.2155
MACD Histogram -0.0756
Fundamentals Value
Market Cap 572.85 Million
Num Shares 72.7 Million
EPS -0.22
Price-to-Earnings (P/E) Ratio -35.82
Price-to-Sales 2.18
Price-to-Book 1.57
PEG Ratio -0.62
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.38
Resistance 3 (R3) 8.37 8.20 8.29
Resistance 2 (R2) 8.20 8.07 8.20 8.26
Resistance 1 (R1) 8.04 8.00 8.12 8.05 8.24
Pivot Point 7.87 7.87 7.91 7.87 7.87
Support 1 (S1) 7.71 7.74 7.79 7.72 7.52
Support 2 (S2) 7.54 7.67 7.54 7.50
Support 3 (S3) 7.38 7.54 7.47
Support 4 (S4) 7.39